319: 5428 Stevens MJ, Feldman EL, Greene DA
When the most recent indication for obesity and cardiovascular disease risk reduction came out in March 2024, she said
Yes, Because: Actual costs support this pricing Efficient telehealth model works Scale allows low margins to work Competition prevents price increases Patient demand strong Market Will Stabilize Around: Low-end: $329-$399/month (efficient operators) Mid-range: $400-$549/month (typical providers) High-end: $550-$699/month (premium services) Prices unlikely to go below $300/month: Costs dont support lower pricing Medical oversight required Quality cant be compromised Current pricing is sustainable and will persist
However, repeatedly taking your injection early week after week can gradually shift your actual dosing schedule and create confusion about when you're truly due for your next dose
Conclusion: While Ozempic can be an effective medication for controlling blood sugar levels in patients with type 2 diabetes, it is not without risks
Both medications work through incretin hormone pathways, but their mechanisms, clinical results, and availability differ substantially